Legionella Testing Market
Number of pages: 100 | Report Format: PDF | Published date: March 06, 2023
Historical Years – 2021 | Base Year – 2022 | Forecasted Years – 2023-2031
|
Report Attribute |
Details |
|
Market Size Value in 2022 |
US$ 292.4 million |
|
Revenue Forecast in 2031 |
US$ 594.32 million |
|
CAGR |
8.2% |
|
Base Year For Estimation |
2022 |
|
Forecast Period |
2023-2031 |
|
Historical Year |
2021 |
|
Segments Covered |
Type, End User, and Region |
|
Regional Scope |
North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
According to the deep-dive market assessment study by Growth Plus Reports, the global legionella testing market was valued at US$ 292.4 million in 2022 and is expected to register a revenue CAGR of 8.2% to reach US$ 594.32 million by 2031.
Legionella Testing Market Fundamentals
Legionella testing is detecting the presence of legionella bacteria in water or other environmental samples. Legionella is a bacterium that can cause Legionnaires’ disease, a severe form of pneumonia, and Pontiac fever, a milder flu-like illness. The disease is spread through inhalation of small water droplets that contain the bacteria, typically from contaminated water sources, such as cooling towers, hot tubs, and water systems in buildings. Legionella testing plays a crucial role in identifying and preventing outbreaks of legionnaires’ disease by detecting the presence of bacteria in water systems and other potential sources. The testing can be done using various methods, including culture-based methods, molecular diagnostic techniques, and rapid antigen tests.
Legionella testing is especially important in industries such as healthcare, hospitality, and manufacturing, where the risk of legionnaires’ disease outbreaks is high due to the presence of large water systems and cooling towers. Regulations and guidelines often require testing to ensure the safety of employees and customers. In recent years, the demand for legionella testing has increased due to rising awareness of the disease and government initiatives to improve water quality standards. The legionella testing market is expected to experience significant growth in the coming years, driven by the increase in the incidence of Legionnaires’ disease, the rise in adoption of advanced molecular diagnostic techniques, and the increased demand for safe and hygienic environments due to the COVID-19 pandemic.
[675675756]
Legionella Testing Market Dynamics
The global legionella testing market is estimated to show considerable revenue growth during the forecast period. This can be attributed to the growing prevalence of legionella infections and growing cases of legionella-borne diseases, raising the demand for legionella testing kits in the global market. Additionally, increasing research activities and technological advancements have led to increased product approvals in the market, encouraging global market revenue growth. Furthermore, innovations in microfluidic technologies and the growing adoption of rapid testing technologies, such as UAT (urinary agent testing) and PCR (polymerase chain reaction), are propelling market development. Governments worldwide are taking initiatives to improve water quality standards and prevent outbreaks of legionnaires’ disease. This has led to the implementation of regulations and guidelines that require legionella testing in various industries. Advances in molecular diagnostic techniques have enabled faster and more accurate legionella testing. The development of rapid antigen tests and DNA-based methods has increased the demand for legionella testing in healthcare facilities and other industries. Besides, the pandemic has increased awareness of the importance of maintaining safe and hygienic environments. As a result, many industries are investing in legionella testing to ensure the safety of their employees and customers. Industries such as healthcare, hospitality, and manufacturing require legionella testing to comply with regulations and guidelines. This has led to a growing demand for legionella testing services and products.
However, legionella testing can be costly, especially for large facilities that require frequent testing. This could limit the adoption of legionella testing in some industries, particularly small and medium-sized enterprises. Compliance with regulations and guidelines can be challenging for some industries, particularly those with complex water systems. This could impact the demand for legionella testing services and products. Legionella testing requires skilled professionals with specialized training and expertise. A shortage of such professionals could limit the growth of the market. Alternative methods, such as chemical disinfection and ultraviolet radiation, can also control legionella growth in water systems. This could limit the demand for legionella testing services and products in some industries. While the market is expected to experience significant growth in the coming years, overcoming these restraints will be crucial for the market to realize its full potential.
Legionella Testing Market Ecosystem
The global legionella testing market has been analyzed from three perspectives: type, end user, and region.
Legionella Testing Market by Type
[7657567]
Based on type, the global legionella testing market has been segmented into the direct fluorescent antibody (DFA) testing, culture media, serology, polymerase chain reaction (PCR), and urine antigen testing (UAT).
The urine antigen testing (UAT) segment dominated the global legionella testing market with the largest revenue share in 2022. UATs are non-culture-based tests that help detect the legionella antigen from a pathogen excreted in the urine. It is the most common type of test used for detecting legionella antigens. This testing method has several advantages over traditional microbiological methods, such as convenience and simple testing method, non-invasive nature, and unaffected by prior antibiotic administration, thus encouraging segment development. Additionally, it can obtain large quantities of specimens for concentration and provide faster results, thus boosting segment demand and propelling the market.
The polymerase chain reaction (PCR) segment is estimated to show lucrative growth during the forecast period. PCR testing provides various benefits, such as detecting specific pathogens that are difficult to culture in vitro. Moreover, it is mainly useful in diagnosing extrapulmonary specimens that can be missed by smear and/or culture. This method offers a rapid diagnosis of bacterium, especially for low levels of bacteria in specimens, and is also an efficient method resulting in the growing demand for PCR testing methods, thereby upsurging the overall market revenue growth.
Legionella Testing Market by End User
Based on end user, the global legionella testing market has been segmented into hospitals, diagnostic laboratories, and others.
The diagnostic laboratories segment dominated the market with the largest revenue share in 2022. The growth of this segment can be ascribed to the growing penetration of advanced technologies for diagnosing legionella infection. The hospitals segment accounts for the second-largest revenue share of the market. The growth of this segment can be attributed to the rise in the prevalence of legionella infections among the population, the large patient footfall, and the growth in the need for consultations.
Legionella Testing Market by Region
Geographically, the global legionella testing market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
North America dominated the market with the largest revenue share in 2022. The growth of this region can be attributed to the high prevalence of legionella infections among the population and the high demand for legionella testing. Additionally, growth in R&D activities, advancement in technologies, and continuous approval of novel products also contribute to regional market revenue growth. Furthermore, the rise in government and private initiatives to increase awareness regarding the risk of legionella growth is further propelling the market growth in North America.
Europe accounts for the second largest revenue share in this market owing to its well-developed healthcare system and services due to the rapid adoption of advanced technologies. Asia Pacific is expected to show noticeable growth during the projected period. The growth of this regional market can be attributed to growing incidences of legionella diseases and the increasing geriatric population. Developing infrastructure, expanding healthcare facilities, and rising healthcare expenditure further encourage regional market revenue growth.
Legionella Testing Market Competitive Landscape
The prominent players operating in the global legionella testing market are:
Legionella Testing Market Strategic Developments
The global legionella testing market is expected to be valued at US$ 594.32 million by 2031.
The legionella testing market is expected to grow at a revenue CAGR of 8.2% during the projected period.
The diagnostics devices segment accounts for the largest revenue share of the global legionella testing market.
The lack of skilled and experienced professionals, the high cost of legionella testing, inadequate reimbursement, and stringent regulatory policies are the restraints in the legionella testing market.
Prominent players in the global legionella testing market are QuidelOrtho Corporation, Eurofins Scientific SE, Merck KGaA, Thermo Fisher Scientific Inc., and Alere Inc. (Abbott).
*Insights on financial performance are subject to the availability of information in the public domain